ALKS
Alkermes plc
NASDAQ · Healthcare · Biotechnology · IE
$46.10
−1.66%Margins
Gross margin
84.6%
EBITDA margin
13.1%
EBIT margin
7.0%
Net margin
4.0%
FCF margin
13.3%
3.7%
Return on equity
1.5%
Return on assets
3.5%
Return on invested capital
0.39x
Asset turnover
$251.2M
Cash from operations
$3.91
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026